Cerevel Therapeutics Holdings Revenue, Growth & Competitor Profile

DBA ARYA SCIENCES ACQUISITION CORP II

Company Profile & Annual Report for Cerevel Therapeutics Holdings

Access the complete profile.

Cerevel Therapeutics Holdings Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	222 Jacobs St Unit 200 Cambridge, MA 02141

Note: Revenues for privately held companies are statistical evaluations.


Cerevel Therapeutics Holdings's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Cerevel Therapeutics Holdings's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Cerevel Therapeutics Holdings is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Cerevel Therapeutics Holdings Annual Revenue and Growth Rate

Cerevel Therapeutics Holdings	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Cerevel Therapeutics Holdings's revenues are gauged from an analysis of company filings.

Cerevel Therapeutics Holdings's Income Statement (based on Industry Averages)

Cerevel Therapeutics Holdings P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Cerevel Therapeutics Holdings is developing and marketing. Cerevel Therapeutics Holdings doesn't have any recent trademark applications, indicating Cerevel Therapeutics Holdings is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
JUVMO Pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological and neuropsychological diseases and disorders; pharmaceutical preparations for the prevention and treatment of medical conditions in the field of neuroscience.	12/22/2023
OMRIVY Pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological and neuropsychological diseases and disorders; pharmaceutical preparations for the prevention and treatment of medical conditions in the field of neuroscience.	12/22/2023
DIVTELVI Pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological and neuropsychological diseases and disorders; pharmaceutical preparations for the prevention and treatment of medical conditions in the field of neuroscience.	12/22/2023

See all trademarks and details in the Full Report.

Market Share of Cerevel Therapeutics Holdings's Largest Competitors

A competitive analysis shows these companies are in the same general field as Cerevel Therapeutics Holdings, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Cerevel Therapeutics Holdings. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BROAD INSTITUTE	Cambridge, MA	100
BEIGENE USA	Cambridge, MA	69
ALNYLAM PHARMACEUTICALS	Cambridge, MA	52
SAGE THERAPEUTICS	Cambridge, MA	47
INTELLIA THERAPEUTICS	Cambridge, MA	35
IPSEN BIOPHARMACEUTICALS	Cambridge, MA	34

Other Companies at 222 Jacobs St, Cambridge MA

Company	Headquarters	Revenue ($ MM)
PHILIPS NORTH AMERICA	Cambridge, MA	100
EXACT SCIENCES THRIVE	Cambridge, MA	16
THRIVE EARLIER DETECTION	Cambridge, MA	1
EXACT SCIENCES THRIVE	Cambridge, MA	0

Future Competition: Cerevel Therapeutics Holdings's Fastest Growing Competitors

These companies are in the same general field as Cerevel Therapeutics Holdings and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)